BioNTech counts on shift to cancer drugs after second quarter losses quadruple

Go back to BioNTech counts on shift to cancer drugs after second quarter losses quadruple
(NASDAQ: BNTX) Delayed: 90.32 -0.57 (0.63%)
Previous Close $90.89    52 Week High
Open $89.89    52 Week Low
Day High $91.38    P/E N/A 
Day Low $89.71    EPS
Volume 201,507